VEGFA and breast cancer: Additionally, Moschetta et al. [37] have reported downregulation of hypoxia-inducible factor-1 (HIF-1) and vascular endothelial growth factor (VEGF), the key angiogenic markers in breast cancer after treatment with metformin.